Breast cancer diagnosis* requires precise identification and quantification of tumor characteristics, making efficient and accurate analysis. OptraSCAN’s Breast cancer analysis Solution provides advanced digital pathology tools designed to interpret breast cancer images, helping pathologists identify tumor clusters and quantify invasive carcinoma and DCIS (Ductal Carcinoma In Situ). Our solutions enables pathologists to make critical diagnoses* with greater confidence, efficiency, and precision.
OptraSCAN’s Breast carcinoma analysis solution is an innovative digital pathology algorithm developed to analyze and interpret with high accuracy. This solution identifies and quantifies important parameters like tissue area, tumor area, and invasive cellularity. It also supports biomarker analysis for ER, PR, HER2Neu, Ki67, and P53, offering a comprehensive view of tumor biology to aid in breast cancer diagnostics*.
The algorithm highlights and quantifies tumor areas and invasive carcinoma, providing precise measurements for effective cancer staging.
It distinguishes and measures areas of DCIS and invasive carcinoma, offering insights into cancer aggressiveness and spread.
Supports analysis of key breast cancer biomarkers, including ER, PR, HER2Neu, Ki67, and P53, to aid in understanding tumor behavior and potential treatment response.
Automated analysis minimizes manual effort, improving consistency and reducing the time pathologists spend on labor-intensive quantification tasks.
A robust reporting module provides clear, organized documentation of tumor area, invasive cellularity, and biomarker results, facilitating streamlined case management.
High-resolution whole-slide imaging is used to capture, preserving detail for accurate quantification and analysis.
Images are preprocessed to optimize clarity and checked for adequacy in tumor tissue area, ensuring comprehensive coverage for analysis.
The Breast Carcinoma Analysis Solution identifies tumor regions, measures invasive carcinoma and DCIS, and quantifies key parameters for reliable interpretation.
The system analyzes ER, PR, HER2Neu, Ki67, and P53 expression, generating a detailed report to assist pathologists in making informed diagnostic* and treatment decisions.
Automated identification and quantification of tumor characteristics improve diagnostic* accuracy and reproducibility.
Automated measurements reduce pathologists' workload, allowing them to focus on high-level decision-making and expedite diagnostic* processes.
Biomarker analysis provides valuable insights into tumor biology, supporting tailored treatment strategies for better patient outcomes.
The effectiveness of our Cervical Cancer Analysis Algorithm is supported by rigorous research and clinical validation in 9 hospitals across 10,000 patients as certified by DBT. Utilizing cloud-based digital pathology workflows, we collaborate with leading institutions and experts in the field to ensure our solutions meet the highest standards of accuracy and reliability. Our virtual pathology platforms for telemedicine makes commitment to continuous improvement by refining our algorithms based on the latest scientific findings and clinical feedback to facilitate remote diagnostics* and support rural labs with remote pathology systems, resulting in our algorithm being recognized and awarded by the Government of India.
The effectiveness of OptraSCAN’s Breast Carcinoma Analysis Solution is supported by rigorous research and validation. Collaborations with leading experts and institutions ensure the algorithm maintains high standards of accuracy and consistency, with continuous enhancements based on the latest scientific advancements and clinical feedback.
OptraSCAN’s Breast Carcinoma Analysis Solution is transforming breast cancer diagnostics*, providing pathologists with powerful, data-driven insights to improve patient care. By combining precise tumor quantification with advanced biomarker analysis, we empower pathologists to deliver more accurate and timely diagnoses*.
For more information on our Breast Carcinoma Analysis Solution or to schedule a demonstration, please contact us at info@optrascan.com. Join us in advancing breast cancer diagnostics* through innovation and technology!
